Acts Online
GT Shield

Notices

 

Licence to Compound or Dispense Medicines: Application fee : Notice No. 758 of 2003

Form: Application for a Licence to Compound or Dispense Medicines : Notice No. 759 of 2003

 

Fees Payable in terms of the Provisions of the Medicines and Related Substances Act, 1965 : Notice No. 784 of 2015

 

Registration of Oral Preparations containing Bacterial Strains : Notice No. 1256 of 2017

 

Annual Single Exit Price Adjustment [SEPA] of Medicines and Scheduled Substances for the year 2019 : Notice No. 29 of 2019

Exemption of Medical Devices and In-Vitro Diagnostics (IVDS) from the Provisions of Section 18A and 18B of the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965), as Amended : Notice No. R.685 of 2019

[Repealed] Fees Payable in terms of the Provisions of the Medicines and Related Substances Act, 1965 : Notice No. 695 of 2019

Exemption of Medical Devices and In-Vitro Diagnostics (IVDS) from the Provisions of Sections 18A and 18B of the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965), as Amended : Notice No. 696 of 2019

 

Exclusion of Schedules 2, 3 and 4 substances from the operation of certain provisions of the Act : Notice No. R. 481 of 2020

Exclusion of Schedules 2, 3 and 4 substances from the requirement in Section 22A(6)(f) of the Act : Notice No. 514 of 2020

Exclusion of Medicines, Medical Devices and In Vitro Diagnostics (IVDs) donated to the State from the Operation of certain provisions of the Act : Notice No. R. 585 of 2020

Exclusion of certain alcohol-based hand-rubs from the operation of specified provisions of the Act : Notice No. R. 721 of 2020

 

Notification of Retention Fee Payment : Notice No. R. 164 of 2021

Exclusion of Schedule 2, 3 and 4 substances from the operation of certain provisions of the Act : Notice No. 252 of 2021

Exclusion of certain alcohol-based hand-rubs from the operation of specified provisions of the Act : Notice No. R. 756 of 2021

Exclusion of COVID-19 Vaccines from the Operation of Certain Provisions of the Act : Notice No. 1502 of 2021

Exclusion of Schedule 0 Medicines from the Operation of Sections 22G and 18A of the Act : Notice No. 1581 of 2021

Extension to the Exemption of Medical Devices and In-Vitro Diagnotistics (IVDs) from the Provisions of Section 18A and Section 18B of the Act: Notice No. R. 1632 of 2021

 

Annual Single Exit Price Adjustment [SEPA] of Medicines and Scheduled Substances for the year 2023 : Notice No. 2940 of 2023

Exclusion of certain alcohol-based hand-rubs from the operation of certain provisions of the Act : Notice No. 3382 of 2023

Exclusion of Schedule Zero (0) Medicines from the operations of Sections 22G and 18A of the Act : Notice No. 3800 of 2023

Second Single Exit Price Increase [SEPI] of Medicines and Scheduled Substances for the year 2023 [Top-up SEPI] : Notice No. 3801 of 2023

 

Exemption of Manufacturers, Wholesalers and Distributors of Class A Medical and In Vitro Diagnostics from the Operation of the provisions of Section 22C of the Act : Notice No. 4406 of 2024

Exclusion of Medicines from the application of certain provisions of Regulation 12 of the General Regulations made in terms of the Act : Notice No. 5361 of 2024